N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide

C34H50N2O6 — CID 42773426

IUPACN-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide
SMILESCCCCCCCCCCCCCC(=O)N(CC(=O)N(Cc1ccc2c(c1)OCO2)Cc1ccco1)CC1CCCO1
InChIInChI=1S/C34H50N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-17-33(37)36(25-30-16-14-21-40-30)26-34(38)35(24-29-15-13-20-39-29)23-28-18-19-31-32(22-28)42-27-41-31/h13,15,18-20,22,30H,2-12,14,16-17,21,23-27H2,1H3
InChIKeyUGOSMSSQELQZCE-UHFFFAOYSA-N
MW582.78 g/mol
LogP7.25
Rot. Bonds20

About N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide

N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide (PubChem CID 42773426) has the molecular formula C34H50N2O6 and a molecular weight of 582.78 g/mol. Its IUPAC name is N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide.

Molecular Properties

Compound NameN-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide
PubChem CID42773426
Molecular FormulaC34H50N2O6
Molecular Weight582.78 g/mol
Exact Mass582.37
IUPAC NameN-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide
SMILESCCCCCCCCCCCCCC(=O)N(CC(=O)N(Cc1ccc2c(c1)OCO2)Cc1ccco1)CC1CCCO1
InChIInChI=1S/C34H50N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-17-33(37)36(25-30-16-14-21-40-30)26-34(38)35(24-29-15-13-20-39-29)23-28-18-19-31-32(22-28)42-27-41-31/h13,15,18-20,22,30H,2-12,14,16-17,21,23-27H2,1H3
InChIKeyUGOSMSSQELQZCE-UHFFFAOYSA-N
XLogP7.25
TPSA81.45 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds20
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500582.78
LogP ≤ 57.25
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide?
The IUPAC name of N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide (CID 42773426) is N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide.
What is the SMILES notation for N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide?
The canonical SMILES for N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide is CCCCCCCCCCCCCC(=O)N(CC(=O)N(Cc1ccc2c(c1)OCO2)Cc1ccco1)CC1CCCO1.
What is the InChIKey of N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide?
The InChIKey is UGOSMSSQELQZCE-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H50N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-17-33(37)36(25-30-16-14-21-40-30)26-34(38)35(24-29-15-13-20-39-29)23-28-18-19-31-32(22-28)42-27-41-31/h13,15,18-20,22,30H,2-12,14,16-17,21,23-27H2,1H3.
What are the key properties of N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide?
N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide has a molecular weight of 582.78 g/mol, XLogP of 7.25, 20 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[1,3-benzodioxol-5-ylmethyl(furan-2-ylmethyl)amino]-2-oxoethyl]-N-(oxolan-2-ylmethyl)tetradecanamide is sourced from PubChem (CID 42773426), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).